|
|
| 11. |
The answer is (gently) blowing in the wind? |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 687-688
G.P. Marelich,
T.E. Albertson,
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 12. |
Cocaine and beta-adrenergic blockersA remarriage after a decade-long divorce? |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 688-689
Jerrold B. Leikin,
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 13. |
Elevated hypoxanthine in endotoxic shock |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 690-691
Theodore A. Alston,
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 14. |
DESIGN AWARD FOR ADULT INTENSIVE CARE UNITS |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 691-691
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 15. |
Staphylococcus aureus infections in trauma patients |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 692-693
John N.,
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 16. |
Intrahospital transport of critically ill children-Should we pay attention? |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 694-695
Shekhar T.,
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 17. |
Appraising the potential of pentoxifylline in septic premies |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 695-697
Jerry J.,
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 18. |
CAROLINA/VIRGINIA CHAPTER SYMPOSIUM |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 697-697
&NA;,
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 19. |
In MemoriumLerner Brady Hinshaw, PhD, FCCM |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 698-698
Fletcher B. Taylor,
Preview
|
|
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
| 20. |
Effects of ibuprofen on the physiology and survival of hypothermic sepsis |
| |
Critical Care Medicine,
Volume 27,
Issue 4,
1999,
Page 699-707
Murray M. Arons,
Arthur P. Wheeler,
Gordon R. Bernard,
Brian W. Christman,
James A. Russell,
Roland Schein,
Warren R. Summer,
Kenneth P. Steinberg,
William Fulkerson,
Patrick Wright,
William D. Dupont,
Bridgett B. Swindell,
Preview
|
|
摘要:
ObjectivesThe objective was to compare the clinical and physiologic characteristics of febrile septic patients with hypothermic septic patients; and to examine plasma levels of cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) and the lipid mediators thromboxane B2(TxB2) and prostacyclin in hypothermic septic patients in comparison with febrile patients. Most importantly, we wanted to report the effect of ibuprofen treatment on vital signs, organ failure, and mortality in hypothermic sepsis.SettingThe study was performed in the intensive care units (ICUs) of seven clinical centers in the United States and Canada.PatientsFour hundred fifty-five patients admitted to the ICU who met defined criteria for severe sepsis and were suspected of having a serious infection.InterventionIbuprofen at a dose of 10 mg/kg (maximum 800 mg) was administered intravenously over 30 to 60 mins every 6 hrs for eight doses vs. placebo (glycine buffer vehicle).Measurements and Main ResultsForty-four (10%) septic patients met criteria for hypothermia and 409 were febrile. The mortality rate was significantly higher in hypothermic patients, 70% vs. 35% for febrile patients. At study entry, urinary metabolites of TxB2, prostacyclin, and serum levels of TNF-alpha and IL-6 were significantly elevated in hypothermic patients compared with febrile patients. In hypothermic patients treated with ibuprofen, there was a trend toward an increased number of days free of major organ system failures and a significant reduction in the 30-day mortality rate from 90% (18/20 placebo-treated patients) to 54% (13/24 ibuprofen-treated patients).ConclusionsHypothermic sepsis has an incidence of [similar]10% and an untreated mortality twice that of severe sepsis presenting with fever. When compared with febrile patients, the hypothermic group has an amplified response with respect to cytokines TNF-alpha and IL-6 and lipid mediators TxB2and prostacyclin. Treatment with ibuprofen may decrease mortality in this select group of septic patients. (Crit Care Med 1999; 27:699-707)
ISSN:0090-3493
出版商:OVID
年代:1999
数据来源: OVID
|
|
首页
